Accessibility Menu
Cspc Pharmaceutical Group logo

Cspc Pharmaceutical Group(OTC) CHJTF

Current Price$1.07
Market Cap$12.33BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2003)+221%
5 Year-10%
1 Year+6%
1 Month+11%
Cspc Pharmaceutical Group last closing stock price
MetricPriceDate
Last closeUSD 1.072026-07-24
Cspc Pharmaceutical Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+11.44%USD 0.962026-06-15
1 month+11.44%USD 0.962026-06-15
3 month+3.93%USD 1.032026-04-24
Year to date+14.71%USD 0.932025-12-01
1 year+5.88%USD 1.012025-06-18
3 year+48.26%USD 0.722023-07-10
5 year-10.14%USD 1.192021-07-09
Since inception+221.13%USD 0.332003-07-01

Cspc Pharmaceutical Group Financials at a Glance

Market Cap

$12.33BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥55.51B

Net Income (TTM)

CN¥5.98B

EPS (TTM)

$0.05

P/E Ratio

22.72

Dividend

$0.04

Beta (Volatility)

0.00 (Low)

Price

$1.07

Volume

5,000

Open

$1.07

Previous Close

$1.07

Daily Range

$1.07 - $1.07

52-Week Range

$0.94 - $1.39

Estimated Earnings Date

Aug 26, 2026

CHJTF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cspc Pharmaceutical Group

CSPC Pharmaceutical Group Limited is a leading investment holding company focused on the research, development, manufacturing, and global commercialization of pharmaceutical products. With a diverse portfolio, the company operates extensively across various international markets, including Asia, the Americas, and Europe.

Products and Services
  • Finished drugs for various medical conditions, including oncology and cardiovascular health
  • Active pharmaceutical ingredients (APIs) such as antibiotics and vitamin C
  • Functional food items and healthcare services
Growth Outlook
  • Revenue of CNY 12.52 billion in Q4 2025, showcasing strong market demand
  • Net income increased to CNY 1.31 billion in Q4 2025, reflecting operational efficiency
  • Robust R&D investment of CNY 3.07 billion in Q4 2025, supporting future product development
Financial Highlights
  • Trailing twelve months (TTM) revenue of CNY 51.5 billion, indicating consistent growth
  • Net profit margin of 14.92% TTM, demonstrating effective cost management
  • Dividend yield of 3.36% TTM, providing attractive returns to shareholders
CSPC Pharmaceutical Group Limited has established itself as a significant player in the pharmaceutical industry, with a strong emphasis on innovation and quality. The company's diverse product offerings cater to a wide range of medical needs, positioning it well for future growth. Recent financial performance highlights a solid revenue base and profitability, supported by substantial investments in research and development. The company's commitment to enhancing its product portfolio and expanding its market presence underscores its potential for sustained growth in the competitive pharmaceutical landscape.
AI Generated • Jul 16, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

19,700

CEO

Lei Cai, PhD

Website

www.cspc.com.hk

Headquarters

Shijiazhuang, HE 050035, CN

CHJTF Financials

Key Financial Metrics (TTM)

Gross Margin

65.59%

Operating Margin

15.26%

Net Income Margin

14.92%

Return on Equity

11.47%

Return on Capital

11.43%

Return on Assets

8.16%

Earnings Yield

4.40%

Dividend Yield

3.47%

Payout Ratio

64.44%

Stock Overview

Market Cap

$12.33BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

11.52B

Volume

5.00K

Avg. Volume

903.403

Financials (TTM)

Gross Profit

CN¥37.20B

Operating Income

CN¥9.37B

EBITDA

CN¥11.98B

Operating Cash Flow

CN¥7.88B

Capital Expenditure

-CN¥3.09B

Free Cash Flow

CN¥4.79B

Cash & ST Invst.

CN¥8.87B

Total Debt

CN¥641.24M

Cspc Pharmaceutical Group Performance Analysis

Cspc Pharmaceutical Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 4,594,329,9966.3%
20232023-12-31CNY 4,438,953,006-3.4%
20242024-12-31CNY 4,030,844,707-9.2%
20252025-12-31CNY 3,617,746,108-10.2%
Cspc Pharmaceutical Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30109.1%
Q42024-12-31-15.8%
Q22025-06-30-5.1%
Q42025-12-31-3.8%
Cspc Pharmaceutical Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY 0.084.4%
20232023-12-31CNY 0.07-8.0%
20242024-12-31CNY 0.05-26.6%
20252025-12-31CNY 0.05-7.6%
Cspc Pharmaceutical Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3012.5%
Q42024-12-31-59.3%
Q22025-06-30-74.7%
Q42025-12-31331.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

CN¥12.52B

+60.8%

Gross Profit

CN¥8.21B

-56.1%

Gross Margin

65.57%

N/A

Market Cap

$12.33BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$625.84K

N/A

Employees

19,700

N/A

Net Income

CN¥1.31B

-14.1%

EBITDA

CN¥2.09B

+16.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

CN¥8.87B

-32.3%

Total Debt

CN¥641.24M

-9.3%

Accounts Receivable

CN¥9.55B

-5.7%

Inventory

CN¥3.09B

-10.5%

Long Term Debt

CN¥180.73M

+68.8%

Short Term Debt

CN¥460.42M

-23.2%

Return on Assets

8.16%

N/A

Return on Invested Capital

10.67%

N/A

Free Cash Flow

CN¥2.00B

-4.9%

Operating Cash Flow

CN¥2.76B

-4.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ERFSFEurofins Scientific SE
$73.75-0.36%
RCDTFRecordati S.p.A.
$58.00+0.00%
SGIOYShionogi & Co., Ltd.
$8.68+0.58%
BIOVFSwedish Orphan Biovitrum AB (publ)
$49.03+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About CHJTF

What is the current price of Cspc Pharmaceutical Group?

Cspc Pharmaceutical Group is trading at $1.07 per share.

What is the 52-week range for Cspc Pharmaceutical Group?

Over the past 52 weeks, Cspc Pharmaceutical Group has traded between $0.94 and $1.39.

How much debt does Cspc Pharmaceutical Group have?

As of the most recent reporting period, Cspc Pharmaceutical Group reported total debt of CN¥91.74M.

How much cash does Cspc Pharmaceutical Group have on hand?

Cspc Pharmaceutical Group reported CN¥754.52M in cash and cash equivalents in its most recent financial results.

What is Cspc Pharmaceutical Group’s dividend yield?

Cspc Pharmaceutical Group currently has a dividend yield of 3.47%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services